Institutional Ownership Reviva Pharmaceuticals Hldgs C (RVPHW)
This table provides information about the institutional ownership of Reviva Pharmaceuticals Hldgs C (RVPHW). We have compiled data on the 6 institutions that hold shares in the stock, with a total of 157,928 shares, which have been reported (via 13F filing form) to have a value of $39,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Arena Investors LP
New York, NY |
May 15, 2024 Q1 2024 |
85,000
shares
|
$21,250
2.49% of portfolio
|
Q4 2021
New holding
|
|
|
Walleye Capital LLC
Plymouth, MN |
May 15, 2024 Q1 2024 |
33,718
shares
|
$8,429
0.0% of portfolio
|
Q2 2023
Reduced 37.92%
|
|
|
Walleye Trading LLC
Plymouth, MN |
May 15, 2024 Q1 2024 |
25,727
shares
|
$6,431
0.0% of portfolio
|
Q2 2023
Reduced 37.19%
|
|
|
National Asset Management, Inc.
Boca Raton, FL |
May 16, 2024 Q1 2024 |
11,101
shares
|
$2,775
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
Ubs Group Ag
|
May 13, 2024 Q1 2024 |
2,382
shares
|
$595
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Apr 30, 2024 Q1 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q1 2024
New holding
|